Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
View Patent ↗This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.
1. A method of treating complex partial seizure comprising administering cannabidiol (CBD) to a patient wherein the CBD is present in an amount which provides a daily dose of at least 400 mg.
2. The method of claim 1 , wherein CBD is present in an amount which provides a daily dose of from 400 to 800 mg.
3. The method of claim 1 , wherein the CBD is used in combination with tetrahydrocannabivarin (THCV).
4. The method of claim 3 , wherein the THCV is present in an amount which provides a daily dose of at least 1.5 mg.
5. The method of claim 4 , wherein the THCV is present in an amount which provides a daily dose of at least 15 mg.
6. The method of claim 1 , wherein the CBD is present as a plant extract.
7. The method of claim 6 , wherein the plant extract comprises less than 5% by weight of tetrahydrocannabinol (THC) as a percentage of any cannabinoids present in the plant extract.
8. The method of claim 7 , wherein the plant extract comprises less than 1% by weight of tetrahydrocannabinol (THC) as a percentage of any cannabinoids present in the plant extract.
9. The method of claim 1 , wherein the CBD is present as a pure or isolated cannabinoid.
10. The method of claim 3 , wherein the CBD in combination with THCV is present as a plant extract.
11. The method of claim 10 , wherein the plant extract comprises less than 5% by weight of tetrahydrocannabinol (THC) as a percentage of any cannabinoids present in the plant extract.
12. The method of claim 11 , wherein the plant extract comprises less than 1% by weight of tetrahydrocannabinol (THC) as a percentage of any cannabinoids present in the plant extract.
13. The method of claim 3 , wherein the CBD in combination with THCV is present as a pure or isolated cannabinoid.